Marrone Bio Innovations Inc  

(Public, NASDAQ:MBII)   Watch this stock  
Find more results for NANCY G. BOYD
0.874
-0.016 (-1.79%)
Jul 28 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 0.82 - 0.91
52 week 0.60 - 4.00
Open 0.89
Vol / Avg. 8,767.00/134,109.00
Mkt cap 21.25M
P/E     -
Div/yield     -
EPS -1.68
Shares 24.58M
Beta     -
Inst. own 41%
May 25, 2016
Marrone Bio Innovations Inc Annual Shareholders Meeting
May 12, 2016
Q1 2016 Marrone Bio Innovations Inc Earnings Call
May 12, 2016
Q1 2016 Marrone Bio Innovations Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin -347.55% -446.16%
Operating margin -279.21% -402.58%
EBITD margin - -366.77%
Return on average assets -55.03% -58.94%
Return on average equity - -280.23%
Employees 86 -
CDP Score - -

Address

1540 Drew Ave
DAVIS, CA 95618-6320
United States - Map
+1-530-7502800 (Phone)
+1-302-5313150 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Marrone Bio Innovations, Inc. offers bio-based pest management and plant health products. The Company's bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene. Its products are used in both conventional and organic crop production, and are sold to growers of specialty crops, such as grapes, citrus, tomatoes, vegetables, nuts, leafy greens and ornamental plants. It offers Regalia for large-acre row crops, such as corn and soybeans. Its pipeline of early-stage discoveries and product candidates extends across a range of product types for end markets, including herbicides, fungicides, nematicides, insecticides, algaecides (for algae control), molluscicides (for mussel and snail control), and plant growth and plant stress regulators. It is engaged in developing MBI-010, MBI-110, Haven (MBI-505) and MBI-601.

Officers and directors

Timothy T. Fogarty Chairperson of the Board
Age: 54
Bio & Compensation  - Reuters
Pamela G. Marrone Ph.D. Chief Executive Officer, Director
Age: 58
Bio & Compensation  - Reuters
James B. Boyd Chief Financial Officer, Vice President
Age: 61
Bio & Compensation  - Reuters
Alison Stewart Senior Vice President - R&D, Chief Technical Officer
Age: 57
Bio & Compensation  - Reuters
Linda V Moore Chief Compliance Officer, Vice President, General Counsel
Bio & Compensation  - Reuters
Nancy Hood Vice President - Marketing
Bio & Compensation  - Reuters
Keith Pitts Vice President of Regulatory and Government Affairs
Age: 50
Bio & Compensation  - Reuters
Phyllis Himmel Vice President - Research & Development
Age: 62
Bio & Compensation  - Reuters
Michael Benoff Director
Bio & Compensation  - Reuters
George H. Kerckhove Director
Age: 77
Bio & Compensation  - Reuters